The use of uric acid in the treatment of multiple sclerosis

被引：0
|
作者：
Koprowski, Hilary [1 ]
机构：
[1] Thomas Jefferson Univ, Ctr Neurovirol, Inst Biotechnol & Adv Mol Med, Philadelphia, PA 19107 USA
来源：
JOURNAL OF NEUROVIROLOGY | 2004年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [31] Serum Uric Acid Level and Multiple Sclerosis: A Mendelian Randomization Study
    Niu, Peng-Peng
    Song, Bo
    Wang, Xue
    Xu, Yu-Ming
    FRONTIERS IN GENETICS, 2020, 11
  • [32] Uric acid levels in patients with multiple sclerosis: a double matched study
    Koutoula, O.
    Papadopoulos, K.
    Paschalidou, M.
    Taskos, N.
    Milonas, I.
    MULTIPLE SCLEROSIS, 2007, 13 : S38 - S38
  • [33] Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
    Dujmovic, Irena
    Pekmezovic, Tatjana
    Obrenovic, Radmila
    Nikolic, Aleksandra
    Spasic, Mihailo
    Stojkovic, Marija Mostarica
    Drulovic, Jelena
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (07) : 848 - 853
  • [34] Serum uric acid levels in multiple sclerosis patients correlate with disability
    Guerrero, A. L.
    Laherran, E.
    Gutierrez, F.
    Martin-Polo, J.
    Gurruchaga, A.
    Rodriguez-Gallego, M.
    Alcazar, C.
    Peralta, J.
    MULTIPLE SCLEROSIS, 2006, 12 : S89 - S90
  • [35] The Relationship Between the Multiple Sclerosis and Endogenous Antioxidan Serum Uric Acid
    不详
    TURKISH JOURNAL OF NEUROLOGY, 2007, 13 (06)
  • [36] Increase of uric acid and purine compounds in serum of multiple sclerosis patients
    Batocchi, A. P.
    Tavazzi, B.
    Frisullo, G.
    Amorini, A. M.
    Nociti, V.
    Plantone, D.
    Patanella, A. K.
    Petzold, A.
    Eikelenboom, J.
    Keir, G.
    Belli, A.
    Giovannoni, G.
    Di Pietro, V.
    Polman, C. H.
    Uitdehaag, B.
    Picardi, M.
    Cordoano, S.
    D'Urso, S.
    Lazzarino, G.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S203 - S204
  • [37] Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients
    Atya H.B.
    Ali S.A.
    Hegazy M.I.
    El Sharkawi F.Z.
    Indian Journal of Clinical Biochemistry, 2018, 33 (2) : 163 - 170
  • [38] Use of dimethylfumarate for the treatment of multiple sclerosis
    Moron Romero, R.
    Gomez Pena, C.
    Garcia Fernandez, C.
    Valle Corpas, M.
    Belda Rustarazo, S.
    Gonzalez Medina, M. C.
    Blanquez Martinez, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 587 - 588
  • [39] Use of mitoxantron in the treatment of multiple sclerosis
    Sivertseva, S. A.
    Zhuravlev, M. N.
    Shmurygina, E. A.
    Dekhtiarenko, E. V.
    Boyko, A. N.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (07) : 100 - 106
  • [40] Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients
    Amorini, Angela M.
    Petzold, Axel
    Tavazzi, Barbara
    Eikelenboom, Judith
    Keir, Geoffrey
    Belli, Antonio
    Giovannoni, Gavin
    Di Preto, Valentina
    Polman, Chris
    D'Urso, Serafina
    Vagnozzi, Roberto
    Uitdehaag, Bernard
    Lazzarino, Giuseppe
    CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 1001 - 1006
12345